Please use this identifier to cite or link to this item:
https://doi.org/10.3390/ijms21134731
DC Field | Value | |
---|---|---|
dc.title | Identification of matrine as a novel regulator of the CXCR4 signaling axis in tumor cells | |
dc.contributor.author | Jung, Y.Y. | |
dc.contributor.author | Um, J.-Y. | |
dc.contributor.author | Narula, A.S. | |
dc.contributor.author | Namjoshi, O.A. | |
dc.contributor.author | Blough, B.E. | |
dc.contributor.author | Kumar, A.P. | |
dc.contributor.author | Ahn, K.S. | |
dc.date.accessioned | 2021-08-27T04:26:53Z | |
dc.date.available | 2021-08-27T04:26:53Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Jung, Y.Y., Um, J.-Y., Narula, A.S., Namjoshi, O.A., Blough, B.E., Kumar, A.P., Ahn, K.S. (2020). Identification of matrine as a novel regulator of the CXCR4 signaling axis in tumor cells. International Journal of Molecular Sciences 21 (13) : 1-17. ScholarBank@NUS Repository. https://doi.org/10.3390/ijms21134731 | |
dc.identifier.issn | 1661-6596 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/199788 | |
dc.description.abstract | Matrine, a quinolizidine alkaloid, is commonly employed for treating various viral and inflammatory disorders. Here, we have evaluated matrine for its activity on C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinases (MMP-9/2) expression, and its potential to affect tumor metastasis and invasion. The effects of matrine on CXCR4, MMP-9/2, and nuclear factor ?B (NF-?B) activation in lung (A549), prostate (DU145), and pancreas (MIA PaCa-2) cells were investigated by diverse techniques. The expression level of CXCR4 and MMP-9/2 was analyzed by western blot analysis and reverse transcription polymerase chain reaction. NF-?B activation was also evaluated by western blot analysis, electrophoretic mobility shift assay as well as immunocytochemical experiments. Furthermore, we monitored cell invasion and metastasis activities by wound healing and Boyden chamber assays. We noted that matrine induced a down-regulation of CXCR4 and MMP-9/2 at both protein and mRNA levels. In addition, matrine negatively regulated human epidermal growth factor receptor 2 (HER2) and C-X-C Motif Chemokine Ligand 12 (CXCL12)-induced CXCR4 expression. Moreover, NF-?B suppression by matrine led to inhibition of metastatic potential of tumor cells. Our results suggest that matrine can block the cancer metastasis through the negative regulation of CXCR4 and MMP-9/2 and consequently it can be considered as a potential candidate for cancer therapy. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.publisher | MDPI AG | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2020 | |
dc.subject | CXCR4 | |
dc.subject | Matrine | |
dc.subject | MMP-9/2 | |
dc.subject | NF-kB | |
dc.type | Article | |
dc.contributor.department | PHARMACOLOGY | |
dc.description.doi | 10.3390/ijms21134731 | |
dc.description.sourcetitle | International Journal of Molecular Sciences | |
dc.description.volume | 21 | |
dc.description.issue | 13 | |
dc.description.page | 1-17 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3390_ijms21134731.pdf | 2.45 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License